KATY

 

KATY is a project funded by the European Union, aimed at developing AI-supported personalized medicine for patients. Cancer treatments urgently need innovative approaches to discover tailored, targeted therapies for patients, with personalized medicine playing a crucial role. Tailored, targeted therapies in cancer treatment are already a reality, but they currently rely on traditional methods of data analysis. AI-supported personalized medicine has the potential to elevate these therapies to a new level. However, regardless of how precise these technologies are, how many lives they can potentially save, or how they can utilize comprehensive medical knowledge – if clinicians do not understand the AI’s suggestions and decisions, AI-supported personalized medicine will not be a game changer. Clinicians will not use it in their daily decision-making, leading to its inevitable failure. Therefore, the real challenge lies in developing AI-supported systems for personalized medicine that can be accepted and understood by clinicians and clinical researchers.

 

In the project KATY, we grasp the above challenge and propose an AI-empowered personalized medicine system that can bring medical “AI-empowered knowledge” to the tips of the fingers of clinicians and clinical researchers. The AI-empowered knowledge is a human interpretable knowledge that clinicians and clinical researchers can understand, trust and effectively use in their everyday working routine. KATY is then an AI-empowered Personalized Medicine system built around two main components: a distributed knowledge graph and a pool of explainable Artificial Intelligence predictors. As a stress test and due to the lack of personalized clinical responses, KATY will be experimented in a low prevalence and complex cancer: Clear Cell Renal Cell Carcinoma (CCRCC). 

More information on the project is available here and in ucris.

 

Experts of the Department working on this project: